J&J/McNeil Done With Post-Recall Personnel Changes – CEO Weldon
Executive Summary
Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.
You may also be interested in...
J&J, FDA Share Blame On Motrin "Phantom Recall"
FDA's Sharfstein says agency "could've done better" in asking questions after it was contacted by J&J about problems with Motrin.
J&J Recalled To Capitol Hill As Besieged Consumer Group Chair Retires
Johnson & Johnson consumer products executive Colleen Goggins' pending retirement could signal a larger executive-level overhaul at the firm
J&J Keeps Expectations Conservative For OTC Manufacturing Remediation
Johnson & Johnson expects the resumption of manufacturing the children's OTC drugs the firm's McNeil Consumer Healthcare business recalled this year may be as far off as April 2011